- Home
- SMXT vs OPTN Comparison
SMXT vs OPTN Comparison
Compare SMXT & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMXT
- OPTN
- Stock Information
- Founded
- SMXT 2008
- OPTN 2010
- Country
- SMXT United States
- OPTN United States
- Employees
- SMXT N/A
- OPTN N/A
- Industry
- SMXT
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- SMXT
- OPTN Health Care
- Exchange
- SMXT NYSE
- OPTN Nasdaq
- Market Cap
- SMXT 67.0M
- OPTN 78.4M
- IPO Year
- SMXT 2024
- OPTN 2017
- Fundamental
- Price
- SMXT $1.58
- OPTN $6.38
- Analyst Decision
- SMXT
- OPTN Strong Buy
- Analyst Count
- SMXT 0
- OPTN 3
- Target Price
- SMXT N/A
- OPTN $16.67
- AVG Volume (30 Days)
- SMXT 408.6K
- OPTN 60.7K
- Earning Date
- SMXT 03-05-2025
- OPTN 03-06-2025
- Dividend Yield
- SMXT N/A
- OPTN N/A
- EPS Growth
- SMXT N/A
- OPTN N/A
- EPS
- SMXT N/A
- OPTN N/A
- Revenue
- SMXT $28,793,764.00
- OPTN $75,672,000.00
- Revenue This Year
- SMXT N/A
- OPTN $13.42
- Revenue Next Year
- SMXT N/A
- OPTN $38.54
- P/E Ratio
- SMXT N/A
- OPTN N/A
- Revenue Growth
- SMXT N/A
- OPTN 5.13
- 52 Week Low
- SMXT $0.60
- OPTN $4.82
- 52 Week High
- SMXT $15.88
- OPTN $31.50
- Technical
- Relative Strength Index (RSI)
- SMXT N/A
- OPTN 49.78
- Support Level
- SMXT N/A
- OPTN $5.16
- Resistance Level
- SMXT N/A
- OPTN $6.97
- Average True Range (ATR)
- SMXT 0.00
- OPTN 0.66
- MACD
- SMXT 0.00
- OPTN 0.10
- Stochastic Oscillator
- SMXT 0.00
- OPTN 71.08
About SMXT SOLARMAX TECHNOLOGY INC
SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.